Both Paxlovid, molnupiravir lower COVID Omicron deaths, hospitalizations -- studies

Both Paxlovid, molnupiravir lower COVID Omicron deaths, hospitalizations, studies conclude AsiaVision / iStock CIDRAP

Two new studies describe the benefits of the antiviral drugs nirmatrelvir-ritonavir (Paxlovid) and molnupiravir in reducing SARS-CoV-2 Omicron hospitalizations and death, with one finding that the former is more effective than the latter at lowering death rates.

Paxlovid and molnupiravir are used to treat nonhospitalized COVID-19 patients at high risk for severe illness within 5 days after symptom onset. 

...